DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. Aortic stenosis.

TAVR 111

TAVR Stenosis Aortic Aortic valve 111

DAIC

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve replacement (SAVR) and other TAVR valves. Evolut vs. 10.6%

TAVR 111

TAVR Aortic valve Aortic Stenosis 111

Heart BMJ

JANUARY 29, 2025

Background Subclinical leaflet thrombosis (SLT) is a common complication after transcatheter aortic valve replacement (TAVR). Our study aimed to use an innovative wearable acoustic cardiography (ACG) device to diagnose SLT as an alternative option. We collected and analysed clinical data including ACG measurements and imaging results.

Aortic valve 52

Aortic valve Thrombosis Aortic Technology 52

DAIC

MAY 1, 2024

The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105

DAIC

DECEMBER 26, 2023

reported results from a clinical study of revolutionary earbuds that use a new technology - In-ear Infrasonic Hemodynography to Detects Aortic Stenosis Murmur Before and After Transcatheter Aortic Valve Replacement (TAVR). milla1cf Tue, 12/26/2023 - 21:36 December 26, 2023 — MindMics, Inc. the R&D Manager of MindMics.

Stenosis 59

Stenosis Technology Aortic Aortic valve 59

DAIC

FEBRUARY 29, 2024

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Frontiers in Cardiovascular Medicine

MARCH 5, 2025

This implementation of novel and successful interventional treatment led to the rapid relief of coronary obstruction.DiscussionThis innovative approach offers a promising avenue for further management of these patients in critical conditions.

Aortic valve 52

Aortic valve Aortic Bicuspid/Mitral TAVR 52